Prognostic risk prediction model construction system and method based on chronic disease real-world data
By constructing a prognostic risk prediction model system based on real-world data of chronic diseases, the problems of low data quality and lack of consideration of comorbidity characteristics in chronic liver disease, diabetes, and hypertension have been solved. This has enabled high-quality data processing and individualized risk quantification, improving the clinical adaptability and translational efficiency of the model.
Patent Information
- Application Number
- CN202610568536.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-04-28
- Publication Date
- 2026-07-03
AI Technical Summary
In existing technologies, there is a lack of standardized solutions for processing real-world data on chronic liver disease, diabetes, and hypertension. The quality of multi-source heterogeneous data is low, the models do not consider comorbidity features, the prediction results have poor clinical adaptability, the model training process is not optimized for bias, and there is a lack of individualized risk quantification and clinical interpretation, resulting in low efficiency of the models in clinical applications.
A prognostic risk prediction model system based on real-world data of chronic diseases is constructed, including multi-source data collection and access, data standardization and quality control, multi-dimensional feature engineering and screening, comorbidity feature fusion, prognostic risk prediction model training and optimization, multi-dimensional model validation and evaluation, deployment and risk stratification output. It adopts clinical-data dual-dimensional feature screening, multi-model fusion and hyperparameter optimization, and combines quantitative formulas to realize individualized risk calculation.
It improved data quality, enhanced the clinical adaptability and robustness of the model, achieved individualized risk quantification and interpretable prediction results, improved the translation efficiency of the model from the laboratory to the clinic, and supported the development of individualized intervention programs.